documents: FDA-1999-D-0081-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1999-D-0081-0001 FDA FDA-1999-D-0081 Draft "Guidance for Industry: Supplemental Guidance on Testing for Replication Competent Retrovirus in Retroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors;" Availability Notice Notice of Data Availability 1999-11-03T05:00:00Z 1999 11 1999-11-03T05:00:00Z 2000-02-02T04:59:59Z 2025-07-01T20:17:52Z 99-28560 0 0 09000064804a694a

Links from other tables